original ) (raw )Apolipoprotein ɛ4 and neuropsychological performance in Alzheimer's disease and vascular dementia
Suzanne Barrett
Neuroscience Letters, 2010
View PDFchevron_right
Apolipoprotein E ɛ4–related effects on cognition are limited to the Alzheimer’s disease spectrum
Pilar Zuluaga
GeroScience
View PDFchevron_right
Neurobiological basis of Alzheimer’s Disease Basic Features and Causal Theories.docx
Theofanis Martinis
View PDFchevron_right
Peripheral Inflammation,Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction
David Fardo
ASN Neuro, 2017
View PDFchevron_right
Stroke and Apolipoprotein E 4 Are Independent Risk Factors for Cognitive Decline : A Population-Based Study
Elizabeth Corder
Stroke, 2000
View PDFchevron_right
Family History of Alzheimer's Disease and Hippocampal Structure in Healthy People
Laurel Martin-harris , Prabha Siddarth
American Journal of Psychiatry, 2010
View PDFchevron_right
A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease
Patrizia Mecocci
Journal of Alzheimer's disease : JAD, 2017
View PDFchevron_right
Effects of Family History and Apolipoprotein E ε4 Status on Cognitive Decline in the Absence of Alzheimer Dementia
John Breitner
Archives of Neurology, 2009
View PDFchevron_right
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease
Judes Poirier
Proceedings of the National Academy of Sciences, 1995
View PDFchevron_right
APOE-4 Genotype and Neurophysiological Vulnerability to Alzheimer's and Cognitive Aging
Alison Burggren
Annual Review of Clinical Psychology, 2009
View PDFchevron_right
Impact of apolipoprotein ɛ4–cerebrospinal fluid beta-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment
Duygu Tosun
Alzheimer's & Dementia, 2011
View PDFchevron_right
Neurobiological aspects of Alzheimer's disease
Anurag Kuhad
Expert Opinion on Therapeutic Targets, 2011
View PDFchevron_right
Apolipoprotein eϵ4, other risk factors, and course of alzheimer’s disease
Gloria Vega , C. Cullum
Biological Psychiatry, 1999
View PDFchevron_right
ApoE, Alzheimer's Disease, and Recovery from Brain Stress
Ann Saunders
Annals of the New York Academy of Sciences, 1997
View PDFchevron_right
The relationship between apolipoprotein e4 and bloodbrain barrier dysfunction in Alzheimer Disease
Vitor Grah
São Paulo Medical Journal, 2021
View PDFchevron_right
The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease
Anders Wallin
Journal of Neurology, Neurosurgery & Psychiatry, 1996
View PDFchevron_right
Peripheral Inflammation, \u3cem\u3eApolipoprotein E4\u3c/em\u3e, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction
David Fardo
2017
View PDFchevron_right
APOE4 Allele Disrupts Resting State fMRI Connectivity in the Absence of Amyloid Plaques or Decreased CSF A 42
Sachin Dixit
Journal of Neuroscience, 2010
View PDFchevron_right
Metabolism of CSF beta-amyloid 42 is affected by vascular risk factors, memory and depressive symptoms differently in cognitively normal APOE-ε4 carriers
Ayesha Khan
Alzheimer's & Dementia, 2012
View PDFchevron_right
Apolipoprotein E ε4 Allele Is Unrelated to Cognitive or Functional Decline in Alzheimer’s Disease: Retrospective and Prospective Analysis
Tracy Rightmer
Dementia and Geriatric Cognitive Disorders, 2006
View PDFchevron_right
Alzheimer disease: An interactome of many diseases
Radha Krsn
Annals of Indian Academy of Neurology, 2014
View PDFchevron_right
Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease
Judes Poirier
Trends in Molecular Medicine, 2003
View PDFchevron_right
ALZHEIMER'S RESEARCH & THERAPY_APOE WMH VBM_2015.pdf
Harald Hampel
View PDFchevron_right
Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease
Travis Stoub
… of the National …, 2006
View PDFchevron_right
Apolipoprotein E genotype, gender and age modulate connectivity of the hippocampus in healthy adults
Nicola Filippini
NeuroImage, 2014
View PDFchevron_right
Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer’s disease
Judes Poirier
Alzheimer's & Dementia, 2008
View PDFchevron_right
APOE and cholesterol homeostasis in Alzheimer's disease
Judes Poirier
Trends in Molecular Medicine, 2010
View PDFchevron_right
Apolipoprotein E, Amyloid, and Alzheimer Disease
JC Dodart
Molecular Interventions, 2002
View PDFchevron_right
Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease
Yi-Ju Li
Neurobiology of Disease, 2006
View PDFchevron_right
Association of Apolipoprotein E-e4 and Dementia Declines with Age
Michal Beeri , James Schmeidler , J. Silverman
The American Journal of Geriatric Psychiatry, 2014
View PDFchevron_right